Aradhana Sarin

Orasure has appointed Aradhana Sarin to its board of directors. She will serve as a Class II director with an initial term expiring at the company's 2020 annual shareholders meeting. She will also serve on the audit committee and nominating and corporate governance committee of the board. Sarin is currently SVP, Head of Corporate Business Development and Strategy for Alexion Pharmaceuticals. She also is Co-Chair of the executive management committee overseeing science and innovation at Alexion. Prior to Alexion, Sarin was at Citi Global Banking and was the Managing Director of Healthcare Corporate & Investment Banking.